Use of a bioengineered skin equivalent for the management of difficult skin defects after pediatric multivisceral transplantation - 21/08/11
, Tomoaki Kato, MD c, Naveen Mittal, MD d, Ahmed Al-Niami, MD c, Barbara Miller c, Andreas G. Tzakis, MD c
Reprint requests: Robert S. Kirsner, MD, PhD, University of Miami, 1201 NW 16th St, Miami, FL 33125.Miami, Florida
Abstract |
Background |
Primary wound closure is not always possible after pediatric multi-visceral transplantation because of oversized donor organs and/or intestinal or graft edema. We report our experience evaluating the safety and efficacy of Graftskin (Apligraf, Organogenesis, Canton, Mass), a bioengineered bi-layered human skin equivalent, for the management of difficult skin abdominal defects after multivisceral transplantation in a pediatric population.
Methods |
A retrospective chart review was performed of pediatric multivisceral transplantation patients who were treated with Graftskin. Adverse events, course of wound reepithelialization, and time for complete closure were recorded.
Results |
Four patients, 7 to 29 months old, were treated with Graftskin. One patient died because of unrelated reasons. Stimulation of the granulation, reepithelialization, and rapid reduction of the wound surface and depth occurred in the other 3 patients. Complete reepithelialization occurred within 5 months. No adverse events were noted.
Conclusion |
Graftskin was a successful treatment for difficult abdominal skin defects after liver and multivisceral transplantation in children.
Le texte complet de cet article est disponible en PDF.Plan
| Funding sources: None. Conflicts of interest: None identified. |
Vol 52 - N° 5
P. 854-858 - mai 2005 Retour au numéro
Article précédent
- Treatment of primary cutaneous B-cell lymphoma with rituximab
- Regina Fink-Puches, Ingrid H. Wolf, Iris Zalaudek, Helmut Kerl, Lorenzo Cerroni
- Contiguous lesions in lentigo maligna
- Scott R. Dalton, Timothy L. Gardner, Lester F. Libow, Dirk M. Elston
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?